[ Price : $8.95]
Federal Register final rule: FDA issues a final rule to amend its medical product intended use regulations.[ Price : $8.95]
FDA defends the accelerated approval process in the wake of Biogens controversial Alzheimers approval and a new BMJ report that si...[ Price : $8.95]
FDA grants Biofourmis a breakthrough device designation for BiovitalsHF, a software medical application that is intended to augmen...[ Price : $8.95]
FDA clears a RealView Imaging 510(k) for its Holoscope-i holographic system for creating spatially accurate, three-dimensional int...[ Price : $8.95]
Federal Register notice: FDA has set the medical device user fee rates for fiscal year 2022.[ Price : $8.95]
Federal Register notice: FDA announces a 10/7 Antimicrobial Drugs Advisory Committee meeting to discuss Takeda's maribivir.[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Request for Samples and Protocols.[ Price : $8.95]
FDA revises Regenerons emergency use authorization for Regen-Cov (casirivimab and imdevimab), expanding its emergency use as post-...